Stem cell-derived beta cell for transplantation
Conventional islet transplants have an important constraint: They are limited.
Intermittent CGM use in type 2 diabetes
Is it an option to use CGM for a limited amount of time? And what would be the rationale to do so?
Why lived experience belongs on every guideline panel
What difference does it make to include people with lived experience in developing clinical guidelines?
Navigating the skies
In this Expert Insights episode, Prof. Julia Mader introduces a project sponsored by the European Union Aviation Safe...
GLP-1 RAs for type 1 diabetes
How safe and effective are adjunct therapies in the era of AID?
What to expect from combined amylin/GLP-1 RA
Could dual-target hormone therapies help close the gap between clinical need and treatment options for obesity with a...
How to manage overweight and obesity
The game has changed for people living with overweight and obesity.
CGM in type 2 diabetes
Can we use CGM to intercept or even revert the progression of early dysglycaemia?
Closed-loop from onset
Should all people newly diagnosed with type 1 diabetes be offered an automated insulin delivery system?
Once-weekly insulins
Why switch from once-daily to once-weekly basal insulin?
What to know about FLOW
A GLP-1 RA kidney trial that was stopped early due to efficacy.
AI in diabetes care and research
Do you wonder if artificial intelligence (AI) would be a good tool in diabetes care?
Real-world evidence
A policy decision made in Belgium based on a real-world trial data demonstrates the potential of real-world evidence.
Screening earlier in pregnancy
New evidence shows that screening for diabetes between weeks 24 and 28 of pregnancy might be too late.
Sports in diabetes management
Physical activity is a cornerstone of diabetes management with numerous benefits, but often challenging impact on glu...
Screening and intervention in T1D
Early screening is essential to identify those at risk of developing T1D.
Diabetes tech in lower income countries
Diabetes technologies hold the potential to improve the daily lives of people with diabetes around the world.
Obesity in type 1 diabetes
As glycaemic control becomes manageable, addressing other aspects of type 1 diabetes care becomes a priority.
Update on weekly insulins
Weekly insulins are the newest major advancement in insulin therapy.
Gender differences in diabetes management
A one-size-fits-all approach to diabetes management is inadequate.
Accessibility and disparities in diabetes therapy
Making diabetes tech available for everybody is possible, but potential socioeconomic and design barriers nee...
Automated insulin delivery in children
While AID systems show great outcomes in achieving time in range goals among paediatric age groups, there are issues ...
Advances in treating diabetes
Over the past 17 years, the ATTD Conference has been a driving force behind innovations in diabetes treatment and tec...